• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN. 3; GLYCOSYLATED HEMOGLOBIN ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HEMOGLOBIN A1CDX GEN. 3; GLYCOSYLATED HEMOGLOBIN ASSAY Back to Search Results
Catalog Number 07559674190
Device Problems High Test Results (2457); Insufficient Information (3190); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/03/2023
Event Type  malfunction  
Manufacturer Narrative
The reagent lot number is 665197.The expiration date was requested but not provided.
 
Event Description
The initial reporter received a questionablea1c-2 tina-quant hemoglobin a1c gen.3 result from one patient sample tested on the cobas c513 analyzer.The initial result was not reported outside of the laboratory.The reporter noticed a positive bias on the analyzer when they compared the results of the patient sample.The patient stated that there were two samples from the patient - sample 1 and sample 2.The initial result of sample 1 from analyzer 2 was 6.3%.The repeat result of sample 1 from analyzer 1 was 6.9% the reporter performed troubleshooting and ran both samples on analyzer 1 and another analyzer (analyzer 3).The results of sample 1 and sample 2 from analyzer 1 were both 6.3%.The results of sample 1 and sample 2 from analyzer 3 were both 6.6%.The result from analyzer 2 was deemed correct.
 
Manufacturer Narrative
Medwatch fields d1 to d3 updated.The investigation reviewed the calibration recovery.The calibration recovery was only provided for the hemoglobin (hb) portion of the assay and did not contain calibration recovery prior to the event.The investigation reviewed the qc recovery.Only the cumulative qc statistics information was provided.Individual qc results were not provided.The investigation reviewed the customer's handling of patient samples; no issues were noted.The investigation reviewed the alarm trace; no issues were noted.The field service engineer (fse) inspected the analyzer and found no cause for the issue.He noted that the analyzer was working within specification.He performed instrument checks with successful results.Based on the information provided, the cause of the event could not be determined.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HEMOGLOBIN A1CDX GEN. 3
Type of Device
GLYCOSYLATED HEMOGLOBIN ASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250-0457
MDR Report Key17655413
MDR Text Key322490012
Report Number1823260-2023-02830
Device Sequence Number1
Product Code LCP
UDI-Device Identifier04015630942787
UDI-Public04015630942787
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K072714
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Catalogue Number07559674190
Device Lot Number66519701
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/07/2023
Initial Date FDA Received08/30/2023
Supplement Dates Manufacturer Received09/05/2023
Supplement Dates FDA Received09/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-